BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 25283854)

  • 1. Human parvovirus B19: a review.
    Rogo LD; Mokhtari-Azad T; Kabir MH; Rezaei F
    Acta Virol; 2014; 58(3):199-213. PubMed ID: 25283854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
    Bieri J; Ros C
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
    Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.
    Adamson-Small LA; Ignatovich IV; Laemmerhirt MG; Hobbs JA
    Virus Res; 2014 Sep; 190():8-16. PubMed ID: 24998884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Replication and Infection of Human Parvovirus B19.
    Ganaie SS; Qiu J
    Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development.
    Xu P; Ganaie SS; Wang X; Wang Z; Kleiboeker S; Horton NC; Heier RF; Meyers MJ; Tavis JE; Qiu J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in human B19 erythrovirus biology.
    Servant-Delmas A; Lefrère JJ; Morinet F; Pillet S
    J Virol; 2010 Oct; 84(19):9658-65. PubMed ID: 20631151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil.
    Cnc Garcia R; Leon LA
    Future Microbiol; 2021 Jan; 16(1):37-50. PubMed ID: 33438475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical use of parvovirus B19 assays: recent advances.
    Gallinella G
    Expert Rev Mol Diagn; 2018 Sep; 18(9):821-832. PubMed ID: 30028234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.
    Xu P; Chen AY; Ganaie SS; Cheng F; Shen W; Wang X; Kleiboeker S; Li Y; Qiu J
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30282717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrovirus B19 infection in humans.
    Kishore J; Kapoor A
    Indian J Med Res; 2000 Nov; 112():149-64. PubMed ID: 12452123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of cidofovir on parvovirus B19 replication.
    Bonvicini F; Bua G; Manaresi E; Gallinella G
    Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions.
    Bua G; Tedesco D; Conti I; Reggiani A; Bartolini M; Gallinella G
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32854437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
    Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
    J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Parvovirus B19 synthetic genome: sequence features and functional competence.
    Manaresi E; Conti I; Bua G; Bonvicini F; Gallinella G
    Virology; 2017 Aug; 508():54-62. PubMed ID: 28500881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions.
    Slavov SN; Kashima S; Pinto AC; Covas DT
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):247-62. PubMed ID: 21585562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Development of Antiviral Strategies against Parvovirus B19.
    Manaresi E; Gallinella G
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.
    Ganaie SS; Chen AY; Huang C; Xu P; Kleiboeker S; Du A; Qiu J
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of brincidofovir on parvovirus B19.
    Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
    Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the human parvovirus B19 biology.
    Servant-Delmas A; Morinet F
    Transfus Clin Biol; 2016 Feb; 23(1):5-12. PubMed ID: 26778837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.